Anlon Healthcare reports 43% revenue growth in FY26; Strengthens growth platform through strategic acquisitions
Jun 01, 2026
Rajkot (Gujarat) [India], June 1: Anlon Healthcare Limited, one of India's leading manufacturers of high-purity pharmaceutical intermediates and active pharmaceutical ingredients (APIs), announced its Audited Financial Results (Standalone and Consolidated) for Q4 and FY26, reporting strong growth in revenue, profitability, and margins, supported by robust R&D execution and strategic capacity expansion initiatives.
Read More...